Oppenheimer Asset Management Inc. lowered its stake in shares of Healthequity Inc (NASDAQ:HQY) by 3.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,877 shares of the company’s stock after selling 348 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Healthequity were worth $581,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Aperio Group LLC raised its stake in Healthequity by 10.3% during the 2nd quarter. Aperio Group LLC now owns 23,738 shares of the company’s stock valued at $1,552,000 after acquiring an additional 2,216 shares in the last quarter. Neuburgh Advisers LLC lifted its position in shares of Healthequity by 5.6% in the first quarter. Neuburgh Advisers LLC now owns 31,600 shares of the company’s stock worth $2,338,000 after buying an additional 1,664 shares during the last quarter. Creative Planning lifted its position in shares of Healthequity by 15.5% in the second quarter. Creative Planning now owns 4,408 shares of the company’s stock worth $288,000 after buying an additional 591 shares during the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in shares of Healthequity by 1.4% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 10,040 shares of the company’s stock worth $657,000 after acquiring an additional 140 shares in the last quarter. Finally, Sawtooth Solutions LLC bought a new stake in shares of Healthequity during the 1st quarter worth about $325,000. 94.77% of the stock is owned by hedge funds and other institutional investors.

Shares of Healthequity stock traded down $2.82 during midday trading on Wednesday, hitting $57.12. The company had a trading volume of 257,734 shares, compared to its average volume of 1,050,584. The business’s 50 day simple moving average is $67.54 and its two-hundred day simple moving average is $70.74. The stock has a market cap of $3.76 billion, a PE ratio of 60.13, a P/E/G ratio of 3.13 and a beta of 1.55. The company has a debt-to-equity ratio of 0.04, a current ratio of 22.98 and a quick ratio of 15.59. Healthequity Inc has a 1-year low of $50.29 and a 1-year high of $101.58.

Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, September 3rd. The company reported $0.36 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.10. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. The firm had revenue of $86.60 million during the quarter, compared to analysts’ expectations of $85.33 million. During the same period in the prior year, the company earned $0.36 EPS. The business’s quarterly revenue was up 21.8% compared to the same quarter last year. On average, sell-side analysts expect that Healthequity Inc will post 0.93 EPS for the current fiscal year.

A number of brokerages have recently weighed in on HQY. Zacks Investment Research upgraded shares of Healthequity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 21st. BidaskClub lowered shares of Healthequity from a “hold” rating to a “sell” rating in a research note on Saturday. Wells Fargo & Co dropped their target price on shares of Healthequity from $80.00 to $76.00 and set an “outperformer” rating on the stock in a report on Wednesday, September 4th. TheStreet lowered shares of Healthequity from a “b” rating to a “c+” rating in a research report on Tuesday, September 3rd. Finally, Bank of America set a $79.00 price target on shares of Healthequity and gave the company a “buy” rating in a report on Wednesday, September 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $81.00.

In related news, CFO Darcy G. Mott sold 4,000 shares of Healthequity stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $71.69, for a total transaction of $286,760.00. Following the transaction, the chief financial officer now owns 58,000 shares of the company’s stock, valued at approximately $4,158,020. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Delano Ladd sold 6,875 shares of Healthequity stock in a transaction that occurred on Monday, July 22nd. The stock was sold at an average price of $80.00, for a total transaction of $550,000.00. Following the transaction, the executive vice president now directly owns 17,833 shares in the company, valued at approximately $1,426,640. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 37,899 shares of company stock valued at $2,751,451. 3.70% of the stock is owned by insiders.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: What is an investor looking for in an SEC filing?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.